Ribbon Biolabs Raises EUR 18 Million Series A Financing for DNA Synthesis Technology
VIENNA, AUSTRIA, January 31, 2022 -- Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in...